rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2000-7-7
|
pubmed:abstractText |
Although triple therapies with a proton pump inhibitor, clarithromycin and either amoxycillin or metronidazole are the most widely accepted treatment for Helicobacter pylori infection, there is no consensus on how long treatment should be maintained for.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0269-2813
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
603-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10792124-Amoxicillin,
pubmed-meshheading:10792124-Anti-Bacterial Agents,
pubmed-meshheading:10792124-Anti-Ulcer Agents,
pubmed-meshheading:10792124-Clarithromycin,
pubmed-meshheading:10792124-Drug Administration Schedule,
pubmed-meshheading:10792124-Drug Therapy, Combination,
pubmed-meshheading:10792124-Helicobacter Infections,
pubmed-meshheading:10792124-Helicobacter pylori,
pubmed-meshheading:10792124-Humans,
pubmed-meshheading:10792124-Metronidazole,
pubmed-meshheading:10792124-Proton Pumps,
pubmed-meshheading:10792124-Treatment Outcome
|
pubmed:year |
2000
|
pubmed:articleTitle |
A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection.
|
pubmed:affiliation |
Serveis de Medicina & Cirurgia i Epidemiologia Clínica, Corporació Sanitària Parc Taulí, Sabadell, Spain. xcalvet@cspt.es
|
pubmed:publicationType |
Journal Article,
Meta-Analysis
|